Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

China · Delayed Price · Currency is CNY

6.82

+0.12 (1.79%)

Sep 30, 2026, 3:00 PM CST

Market Cap	4.72B +3.6%
Revenue (ttm)	2.25B -5.7%
Net Income	323.21M +36.2%
EPS	0.47 +39.4%
Shares Out	692.00M
PE Ratio	14.65
Forward PE	n/a
Dividend	0.30 (4.40%)
Ex-Dividend Date	Sep 1, 2026

Volume	21,178,546
Open	6.70
Previous Close	6.70
Day's Range	6.70 - 6.88
52-Week Range	5.60 - 7.45
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1978

Employees 3,415

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600351

Full Company Profile

Financial Performance

In 2025, SHA:600351's revenue was 2.24 billion, a decrease of -16.60% compared to the previous year's 2.69 billion. Earnings were 320.01 million, an increase of 31.86%.

Financial Statements